eNeura Therapeutics
Sunnyvale
About eNeura Therapeutics
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed’at home, in the office, or on the go.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $75.8M
- Funding stage: Late Stage Venture
- Last round: Debt Financing (Nov 2019)
- Website: eneura.com
- Phone: (667) 401-5580
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/eneura-therapeutics-148207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.